| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.864 | 0.003 | 0.864 | Bronchodilator | 0.558 0.004 DBMET00975 | ||
| 0.828 | 0.004 | 0.828 | Antiadrenergic | 0.509 0.005 DBMET00975 | ||
| 0.825 | 0.004 | 0.825 | Adrenaline antagonist | 0.507 0.005 DBMET00975 | ||
| 0.825 | 0.004 | 0.825 | Spasmolytic | 0.788 0.004 DBMET00975 | ||
| 0.785 | 0.006 | 0.785 | Antiobesity | 0.783 0.006 DBMET00975 | ||
| 0.684 | 0.004 | 0.684 | Psychostimulant | 0.16 0.107 DBMET00975 | ||
| 0.668 | 0.003 | 0.668 | Calcium channel L-type activator | 0.591 0.007 DBMET00975 | ||
| 0.674 | 0.01 | 0.674 | Toll-Like receptor 7 agonist | 0.328 0.094 DBMET00975 | ||
| 0.671 | 0.01 | 0.671 | Toll-Like receptor agonist | 0.359 0.078 DBMET00975 | ||
| 0.642 | 0.006 | 0.642 | Vasodilator, coronary | 0.368 0.047 DBMET00975 | ||
| 0.636 | 0.012 | 0.636 | Vasodilator, peripheral | |||
| 0.641 | 0.021 | 0.641 | Cyclophilin D inhibitor | 0.616 0.025 DBMET00975 | ||
| 0.609 | 0.004 | 0.609 | Peroxidase inhibitor | 0.404 0.02 DBMET00975 | ||
| 0.609 | 0.018 | 0.609 | Aldehyde oxidase inhibitor | |||
| 0.604 | 0.014 | 0.604 | 5 Hydroxytryptamine release stimulant | |||
| 0.588 | 0.033 | 0.588 | Transcription factor NF kappa B inhibitor | 0.447 0.054 DBMET00975 | ||
| 0.527 | 0.002 | 0.527 | Phenylalanine 4-hydroxylase inhibitor | 0.269 0.004 DBMET00975 | ||
| 0.524 | 0.013 | 0.524 | Cardiotonic | 0.28 0.065 DBMET00975 | ||
| 0.508 | 0.004 | 0.508 | Anesthetic local | 0.137 0.055 DBMET00975 | ||
| 0.506 | 0.002 | 0.506 | Adrenaline agonist | 0.293 0.004 DBMET00975 | ||
| 0.487 | 0.002 | 0.487 | Beta adrenoreceptor antagonist | 0.185 0.004 DBMET00975 | ||
| 0.491 | 0.009 | 0.491 | Interleukin agonist | 0.197 0.124 DBMET00975 | ||
| 0.473 | 0.002 | 0.473 | Beta 2 adrenoreceptor antagonist | 0.177 0.004 DBMET00975 | ||
| 0.477 | 0.017 | 0.477 | Hypoxia-inducible factor 1 alpha inhibitor | 0.271 0.083 DBMET00975 | ||
| 0.473 | 0.014 | 0.473 | Vasodilator | 0.272 0.058 DBMET00975 | ||
| 0.486 | 0.037 | 0.486 | 5 Hydroxytryptamine release inhibitor | |||
| 0.438 | 0.009 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.204 0.143 DBMET00975 | ||
| 0.413 | 0.014 | 0.413 | Sodium/bile acid cotransporter inhibitor | 0.39 0.02 DBMET00975 | ||
| 0.404 | 0.016 | 0.404 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.406 | 0.023 | 0.406 | Calcium channel activator | 0.247 0.151 DBMET00975 | ||
| 0.383 | 0.002 | 0.383 | Beta 1 adrenoreceptor antagonist | 0.146 0.005 DBMET00975 | ||
| 0.382 | 0.002 | 0.382 | Beta 3 adrenoreceptor antagonist | 0.212 0.004 DBMET00975 | ||
| 0.426 | 0.048 | 0.426 | Calpain 2 inhibitor | |||
| 0.365 | 0.002 | 0.365 | Beta adrenoreceptor agonist | 0.135 0.003 DBMET00975 | ||
| 0.424 | 0.063 | 0.424 | Histamine release inhibitor | 0.358 0.096 DBMET00975 | ||
| 0.442 | 0.087 | 0.442 | Caspase 9 stimulant | |||
| 0.366 | 0.013 | 0.366 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.145 DBMET00975 | ||
| 0.349 | 0.012 | 0.349 | Peptidyltransferase inhibitor | 0.271 0.038 DBMET00975 | ||
| 0.338 | 0.002 | 0.338 | Adenylate cyclase stimulant | 0.325 0.002 DBMET00975 | ||
| 0.385 | 0.053 | 0.602 | Antithrombotic | 0.602 0.016 DBMET00975 | DBMET00975 | |
| 0.394 | 0.064 | 0.394 | GABA C receptor rho-3 antagonist | |||
| 0.38 | 0.054 | 0.538 | Cholesterol antagonist | 0.538 0.027 DBMET00975 | DBMET00975 | |
| 0.33 | 0.006 | 0.33 | Nitric-oxide synthase stimulant | 0.176 0.139 DBMET00975 | ||
| 0.336 | 0.013 | 0.336 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.357 | 0.036 | 0.357 | Hypoglycemic | |||
| 0.344 | 0.038 | 0.459 | Superoxide dismutase inhibitor | 0.459 0.018 DBMET00975 | DBMET00975 | |
| 0.316 | 0.012 | 0.316 | Acetylcholine M1 receptor antagonist | 0.163 0.064 DBMET00975 | ||
| 0.31 | 0.008 | 0.31 | Acetylcholine muscarinic antagonist | 0.155 0.041 DBMET00975 | ||
| 0.345 | 0.048 | 0.45 | Antioxidant | 0.45 0.027 DBMET00975 | DBMET00975 | |
| 0.306 | 0.013 | 0.306 | Adenylate cyclase inhibitor | 0.126 0.062 DBMET00975 | ||
| 0.355 | 0.063 | 0.423 | Immunostimulant | 0.423 0.043 DBMET00975 | DBMET00975 | |
| 0.293 | 0.004 | 0.293 | Glutamate decarboxylase inhibitor | 0.155 0.012 DBMET00975 | ||
| 0.303 | 0.014 | 0.303 | Cholinergic antagonist | 0.124 0.07 DBMET00975 | ||
| 0.335 | 0.052 | 0.335 | Interleukin 2 agonist | 0.222 0.154 DBMET00975 | ||
| 0.294 | 0.014 | 0.294 | Acetylcholine antagonist | 0.122 0.069 DBMET00975 | ||
| 0.321 | 0.046 | 0.321 | Free radical scavenger | 0.252 0.068 DBMET00975 | ||
| 0.284 | 0.02 | 0.284 | Insulin sensitizer | 0.226 0.05 DBMET00975 | ||
| 0.267 | 0.005 | 0.267 | Acetylcholine M3 receptor antagonist | |||
| 0.266 | 0.011 | 0.266 | Expectorant | 0.127 0.046 DBMET00975 | ||
| 0.259 | 0.005 | 0.259 | Mucolytic | 0.156 0.029 DBMET00975 | ||
| 0.279 | 0.031 | 0.279 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.247 | 0.002 | 0.247 | Beta 2 adrenoreceptor agonist | 0.144 0.003 DBMET00975 | ||
| 0.283 | 0.04 | 0.283 | Calpain inhibitor | |||
| 0.239 | 0.006 | 0.239 | Creatine kinase inhibitor | 0.14 0.028 DBMET00975 | ||
| 0.251 | 0.021 | 0.251 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.231 | 0.006 | 0.231 | Alpha adrenoreceptor agonist | |||
| 0.273 | 0.054 | 0.273 | DNA synthesis inhibitor | 0.175 0.16 DBMET00975 | ||
| 0.215 | 0.002 | 0.215 | Beta 1 adrenoreceptor agonist | 0.054 0.004 DBMET00975 | ||
| 0.22 | 0.009 | 0.22 | Aminoacyl-tRNA synthetase inhibitor | 0.147 0.02 DBMET00975 | ||
| 0.23 | 0.034 | 0.23 | Amylase inhibitor | |||
| 0.21 | 0.015 | 0.236 | Carbonic anhydrase III inhibitor | 0.236 0.011 DBMET00975 | DBMET00975 | |
| 0.225 | 0.033 | 0.225 | Melanin inhibitor | |||
| 0.194 | 0.002 | 0.194 | Beta 3 adrenoreceptor agonist | 0.027 0.004 DBMET00975 | ||
| 0.256 | 0.068 | 0.256 | Antiamyloidogenic | |||
| 0.214 | 0.03 | 0.214 | Monophenol monooxygenase inhibitor | 0.149 0.047 DBMET00975 | ||
| 0.182 | 0.008 | 0.182 | Somatostatin 1 agonist | 0.125 0.021 DBMET00975 | ||
| 0.305 | 0.131 | 0.474 | Antibacterial | 0.474 0.048 DBMET00975 | DBMET00975 | |
| 0.177 | 0.008 | 0.189 | Anabolic | 0.189 0.005 DBMET00975 | DBMET00975 | |
| 0.199 | 0.03 | 0.366 | Cell wall synthesis inhibitor | 0.366 0.007 DBMET00975 | DBMET00975 | |
| 0.201 | 0.032 | 0.525 | Hemostatic | 0.525 0.004 DBMET00975 | DBMET00975 | |
| 0.182 | 0.014 | 0.182 | Sphingomyelinase inhibitor | |||
| 0.24 | 0.072 | 0.24 | Hypolipemic | 0.147 0.14 DBMET00975 | ||
| 0.182 | 0.022 | 0.182 | Carbonic anhydrase XV inhibitor | 0.118 0.048 DBMET00975 | ||
| 0.179 | 0.032 | 0.179 | Nav1.3 sodium channel blocker | |||
| 0.238 | 0.093 | 0.238 | Gastrin inhibitor | |||
| 0.175 | 0.032 | 0.175 | Interleukin 4 antagonist | |||
| 0.259 | 0.119 | 0.259 | Apoptosis antagonist | |||
| 0.156 | 0.018 | 0.156 | Histidine decarboxylase inhibitor | |||
| 0.159 | 0.025 | 0.159 | Mediator release inhibitor | |||
| 0.169 | 0.037 | 0.169 | Alkylator | 0.138 0.053 DBMET00975 | ||
| 0.142 | 0.012 | 0.142 | Carbonic anhydrase stimulant | 0.057 0.044 DBMET00975 | ||
| 0.149 | 0.021 | 0.149 | Electron transport complex I inhibitor | |||
| 0.202 | 0.074 | 0.202 | Neurotrophic factor enhancer | |||
| 0.164 | 0.038 | 0.224 | Cholesterol synthesis inhibitor | 0.224 0.022 DBMET00975 | DBMET00975 | |
| 0.183 | 0.058 | 0.216 | Phospholipase C inhibitor | 0.216 0.035 DBMET00975 | DBMET00975 | |
| 0.162 | 0.039 | 0.162 | Cyclooxygenase 3 inhibitor | |||
| 0.176 | 0.054 | 0.176 | Neurotensin receptor agonist | |||
| 0.146 | 0.027 | 0.146 | Transcription factor STAT6 inhibitor | |||
| 0.145 | 0.027 | 0.181 | Catalase inhibitor | 0.181 0.019 DBMET00975 | DBMET00975 | |
| 0.128 | 0.015 | 0.128 | Acetylcholine M2 receptor antagonist | |||
| 0.147 | 0.035 | 0.147 | GABA C receptor agonist | |||
| 0.151 | 0.04 | 0.151 | Cystathionine beta-synthase inhibitor | |||
| 0.185 | 0.074 | 0.185 | Nitric oxide antagonist | 0.148 0.096 DBMET00975 | ||
| 0.229 | 0.118 | 0.229 | Insulysin inhibitor | |||
| 0.203 | 0.093 | 0.435 | Angiogenesis stimulant | 0.435 0.017 DBMET00975 | DBMET00975 | |
| 0.138 | 0.029 | 0.138 | DOPA decarboxylase inhibitor | |||
| 0.146 | 0.039 | 0.179 | Aminopeptidase B inhibitor | 0.179 0.027 DBMET00975 | DBMET00975 | |
| 0.152 | 0.046 | 0.152 | Proteasome inhibitor | |||
| 0.16 | 0.062 | 0.16 | Lipid peroxidase inhibitor | 0.158 0.063 DBMET00975 | ||
| 0.117 | 0.02 | 0.117 | Aminopeptidase I inhibitor | |||
| 0.121 | 0.025 | 0.121 | Ornithine decarboxylase inhibitor | |||
| 0.107 | 0.013 | 0.107 | Alpha 2 adrenoreceptor agonist | |||
| 0.135 | 0.041 | 0.176 | Nav1.4 sodium channel blocker | 0.176 0.025 DBMET00975 | DBMET00975 | |
| 0.108 | 0.015 | 0.108 | Alpha 1 adrenoreceptor agonist | |||
| 0.164 | 0.071 | 0.245 | Thrombolytic | 0.245 0.035 DBMET00975 | DBMET00975 | |
| 0.146 | 0.053 | 0.146 | Ca2+-transporting ATPase inhibitor | |||
| 0.147 | 0.054 | 0.147 | Toll-Like receptor 2 antagonist | |||
| 0.107 | 0.014 | 0.107 | Maillard reaction inhibitor | |||
| 0.196 | 0.106 | 0.256 | RNA-directed DNA polymerase inhibitor | 0.256 0.046 DBMET00975 | DBMET00975 | |
| 0.103 | 0.015 | 0.161 | Neuraminidase (influenza) inhibitor | 0.161 0.006 DBMET00975 | DBMET00975 | |
| 0.13 | 0.043 | 0.13 | GABA C receptor antagonist | |||
| 0.123 | 0.036 | 0.123 | Prolactin inhibitor | |||
| 0.147 | 0.061 | 0.147 | Neurotrophic factor | |||
| 0.156 | 0.07 | 0.156 | Interferon gamma antagonist | |||
| 0.131 | 0.045 | 0.131 | Photosensitizer | |||
| 0.152 | 0.067 | 0.152 | Protein kinase stimulant | |||
| 0.101 | 0.016 | 0.101 | GABA B receptor agonist | |||
| 0.129 | 0.046 | 0.129 | Chelator | |||
| 0.114 | 0.032 | 0.114 | NADH dehydrogenase inhibitor | |||
| 0.103 | 0.022 | 0.103 | Estrogen-related receptor beta agonist | |||
| 0.239 | 0.158 | 0.239 | Immunosuppressant | |||
| 0.162 | 0.082 | 0.162 | ATPase inhibitor | |||
| 0.123 | 0.042 | 0.123 | Urease inhibitor | |||
| 0.115 | 0.036 | 0.115 | Glutamate (mGluR7) agonist | |||
| 0.118 | 0.041 | 0.118 | Factor V inhibitor | |||
| 0.124 | 0.048 | 0.124 | Estrogen antagonist | |||
| 0.125 | 0.05 | 0.125 | Ferrochelatase inhibitor | |||
| 0.164 | 0.089 | 0.164 | Succinate dehydrogenase inhibitor | |||
| 0.194 | 0.12 | 0.194 | DNA damaging | |||
| 0.078 | 0.005 | 0.078 | Alpha 1d adrenoreceptor agonist | |||
| 0.149 | 0.075 | 0.149 | GABA C receptor rho-2 antagonist | |||
| 0.091 | 0.019 | 0.114 | Neuraminidase inhibitor | 0.114 0.011 DBMET00975 | DBMET00975 | |
| 0.173 | 0.101 | 0.173 | Interleukin antagonist | |||
| 0.116 | 0.044 | 0.116 | GABA C receptor rho-1 antagonist | |||
| 0.083 | 0.012 | 0.083 | Myc inhibitor | |||
| 0.093 | 0.023 | 0.093 | Secretase beta inhibitor | |||
| 0.21 | 0.141 | 0.21 | 12-Lipoxygenase inhibitor | |||
| 0.116 | 0.047 | 0.116 | Adenylate kinase inhibitor | |||
| 0.124 | 0.056 | 0.124 | Microtubule formation inhibitor | |||
| 0.166 | 0.098 | 0.166 | Anesthetic general | |||
| 0.104 | 0.037 | 0.104 | Glutamate release inhibitor | |||
| 0.088 | 0.021 | 0.088 | Acetylcholine M5 receptor antagonist | |||
| 0.076 | 0.009 | 0.076 | Alpha 1b adrenoreceptor agonist | 0.048 0.042 DBMET00975 | ||
| 0.111 | 0.045 | 0.111 | Estrogen receptor beta antagonist | 0.09 0.083 DBMET00975 | ||
| 0.104 | 0.042 | 0.108 | Bile acid receptor antagonist | 0.108 0.035 DBMET00975 | DBMET00975 | |
| 0.263 | 0.201 | 0.263 | Apoptosis agonist | |||
| 0.129 | 0.068 | 0.129 | Vanilloid 1 agonist | |||
| 0.099 | 0.04 | 0.114 | Carbonic anhydrase VI inhibitor | 0.114 0.032 DBMET00975 | DBMET00975 | |
| 0.086 | 0.027 | 0.091 | Phospholipase D inhibitor | 0.091 0.021 DBMET00975 | DBMET00975 | |
| 0.073 | 0.015 | 0.089 | Alpha-mannosidase inhibitor | 0.089 0.008 DBMET00975 | DBMET00975 | |
| 0.106 | 0.047 | 0.106 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.065 | 0.008 | 0.065 | Diamine oxidase inhibitor | |||
| 0.13 | 0.074 | 0.13 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.191 | 0.136 | 0.191 | Neuropeptide Y2 antagonist | |||
| 0.137 | 0.081 | 0.137 | Pregnane X receptor agonist | |||
| 0.133 | 0.077 | 0.133 | Farnesoid X receptor antagonist | |||
| 0.077 | 0.023 | 0.077 | Heat shock protein 90 beta antagonist | |||
| 0.104 | 0.051 | 0.104 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.076 | 0.026 | 0.076 | Alcohol oxidase inhibitor | |||
| 0.157 | 0.107 | 0.157 | P-glycoprotein inhibitor | |||
| 0.138 | 0.088 | 0.138 | Phospholipase A2 inhibitor | |||
| 0.124 | 0.076 | 0.124 | Antibacterial (Helicobacter pylori) | 0.116 0.087 DBMET00975 | ||
| 0.104 | 0.056 | 0.104 | UDP-glucose 4-epimerase inhibitor | |||
| 0.153 | 0.106 | 0.153 | Amyloid beta aggregation inhibitor | |||
| 0.15 | 0.104 | 0.15 | DNA methyltransferase I inhibitor | |||
| 0.111 | 0.065 | 0.111 | Alpha 2b adrenoreceptor antagonist | |||
| 0.05 | 0.005 | 0.05 | Alpha 1a adrenoreceptor agonist | |||
| 0.085 | 0.04 | 0.085 | Glutamate dehydrogenase inhibitor | |||
| 0.061 | 0.016 | 0.078 | Mannosidase inhibitor | 0.078 0.009 DBMET00975 | DBMET00975 | |
| 0.086 | 0.042 | 0.086 | Keratolytic | |||
| 0.082 | 0.04 | 0.082 | MAP kinase kinase 7 inhibitor | |||
| 0.086 | 0.044 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.097 0.035 DBMET00975 | DBMET00975 | |
| 0.057 | 0.015 | 0.057 | Neuraminidase (Influenza A) inhibitor | |||
| 0.055 | 0.014 | 0.055 | Dopamine D5 agonist | |||
| 0.058 | 0.019 | 0.058 | Oxytocin agonist | |||
| 0.043 | 0.004 | 0.043 | Alpha 2a adrenoreceptor agonist | |||
| 0.048 | 0.009 | 0.048 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.09 | 0.052 | 0.09 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.063 | 0.028 | 0.063 | Sphingosine kinase 2 inhibitor | |||
| 0.067 | 0.032 | 0.067 | Cathepsin E inhibitor | |||
| 0.069 | 0.034 | 0.07 | NMDA 2C receptor antagonist | 0.07 0.033 DBMET00975 | DBMET00975 | |
| 0.151 | 0.117 | 0.151 | DNA methylase inhibitor | |||
| 0.09 | 0.056 | 0.09 | Alpha 2 adrenoreceptor antagonist | |||
| 0.052 | 0.019 | 0.052 | Somatostatin 1 antagonist | |||
| 0.085 | 0.054 | 0.085 | Histamine H2 receptor antagonist | |||
| 0.089 | 0.058 | 0.089 | Opioid antagonist | |||
| 0.088 | 0.058 | 0.088 | Interleukin 5 antagonist | |||
| 0.145 | 0.115 | 0.197 | Hepatoprotectant | 0.197 0.067 DBMET00975 | DBMET00975 | |
| 0.034 | 0.004 | 0.034 | Neuraminidase (Influenza B) inhibitor | |||
| 0.034 | 0.005 | 0.034 | Calcium-sensing receptor antagonist | |||
| 0.056 | 0.028 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.035 | 0.007 | 0.046 | 1,3-Beta-glucan synthase inhibitor | 0.046 0.003 DBMET00975 | DBMET00975 | |
| 0.042 | 0.014 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.037 0.021 DBMET00975 | ||
| 0.093 | 0.067 | 0.093 | Phosphodiesterase 6D inhibitor | |||
| 0.061 | 0.034 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.129 | 0.102 | 0.129 | Neuropeptide Y1 antagonist | |||
| 0.062 | 0.035 | 0.062 | Argininosuccinate synthase inhibitor | |||
| 0.096 | 0.07 | 0.131 | Gastric antisecretory | 0.131 0.036 DBMET00975 | DBMET00975 | |
| 0.061 | 0.036 | 0.061 | Ribonucleotide reductase inhibitor | |||
| 0.127 | 0.101 | 0.127 | Insulin secretagoues | |||
| 0.046 | 0.021 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.064 | 0.039 | 0.064 | Purinergic P2X1 antagonist | |||
| 0.059 | 0.034 | 0.059 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.064 | 0.039 | 0.064 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.043 | 0.02 | 0.043 | Arginase inhibitor | |||
| 0.062 | 0.039 | 0.062 | Androgen agonist | 0.054 0.049 DBMET00975 | ||
| 0.13 | 0.107 | 0.13 | Growth hormone agonist | |||
| 0.056 | 0.034 | 0.056 | Ornithine carbamoyltransferase inhibitor | |||
| 0.053 | 0.033 | 0.122 | Factor IXa inhibitor | 0.122 0.005 DBMET00975 | DBMET00975 | |
| 0.056 | 0.036 | 0.056 | Glucosylceramidase inhibitor | |||
| 0.086 | 0.066 | 0.218 | Triose-phosphate isomerase inhibitor | 0.218 0.009 DBMET00975 | DBMET00975 | |
| 0.071 | 0.052 | 0.071 | Glycine receptor agonist | |||
| 0.067 | 0.047 | 0.067 | Purinergic P2X2 antagonist | |||
| 0.059 | 0.04 | 0.085 | Sphingosine kinase inhibitor | 0.085 0.013 DBMET00975 | DBMET00975 | |
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) blocker | |||
| 0.059 | 0.04 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.025 | 0.006 | 0.025 | Ileal bile acid transport inhibitor | |||
| 0.062 | 0.045 | 0.062 | Opioid delta receptor antagonist | |||
| 0.062 | 0.045 | 0.077 | NMDA receptor agonist | 0.077 0.031 DBMET00975 | DBMET00975 | |
| 0.079 | 0.062 | 0.079 | Glutathione S-transferase inhibitor | |||
| 0.031 | 0.015 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.101 | 0.085 | 0.101 | DNA polymerase I inhibitor | |||
| 0.124 | 0.108 | 0.124 | Thiol protease inhibitor | |||
| 0.072 | 0.056 | 0.287 | Carbonic anhydrase XIII inhibitor | 0.287 0.006 DBMET00975 | DBMET00975 | |
| 0.049 | 0.034 | 0.049 | Bombesin 2 receptor antagonist | |||
| 0.071 | 0.056 | 0.071 | Alpha 2a adrenoreceptor antagonist | |||
| 0.08 | 0.066 | 0.103 | NMDA receptor antagonist | 0.103 0.045 DBMET00975 | DBMET00975 | |
| 0.022 | 0.008 | 0.022 | Antibiotic Anthracycline-like | |||
| 0.036 | 0.023 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 DBMET00975 | DBMET00975 | |
| 0.05 | 0.038 | 0.05 | NMDA 2A receptor antagonist | |||
| 0.09 | 0.078 | 0.09 | Nitric-oxide synthase inhibitor | |||
| 0.068 | 0.056 | 0.208 | Cathepsin G inhibitor | 0.208 0.015 DBMET00975 | DBMET00975 | |
| 0.059 | 0.048 | 0.059 | 5 Hydroxytryptamine 2A agonist | |||
| 0.051 | 0.04 | 0.051 | Cathepsin D inhibitor | |||
| 0.071 | 0.06 | 0.071 | Vanilloid 4 agonist | |||
| 0.079 | 0.069 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.074 | 0.063 | 0.074 | Interferon agonist | |||
| 0.042 | 0.033 | 0.042 | Geranyltranstransferase inhibitor | |||
| 0.026 | 0.016 | 0.026 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.073 | 0.064 | 0.073 | Acetylcholine nicotinic antagonist | |||
| 0.054 | 0.046 | 0.054 | Fibroblast growth factor 4 antagonist | |||
| 0.083 | 0.075 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.052 | 0.045 | 0.052 | Cathepsin B inhibitor | |||
| 0.025 | 0.018 | 0.025 | Vanilloid 2 agonist | 0.023 0.022 DBMET00975 | ||
| 0.112 | 0.105 | 0.112 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.082 | 0.076 | 0.082 | Alcohol dehydrogenase inhibitor | |||
| 0.06 | 0.054 | 0.06 | Interferon inducer | |||
| 0.089 | 0.083 | 0.089 | Falcipain 3 inhibitor | |||
| 0.05 | 0.044 | 0.059 | Leukotriene B4 antagonist | 0.059 0.029 DBMET00975 | DBMET00975 | |
| 0.027 | 0.023 | 0.027 | Vasopressin 1A agonist | |||
| 0.027 | 0.024 | 0.027 | Plasmepsin I inhibitor | |||
| 0.129 | 0.126 | 0.129 | Heat shock protein 70 antagonist | |||
| 0.098 | 0.095 | 0.098 | Caspase 3 inhibitor | |||
| 0.084 | 0.081 | 0.084 | Protease inhibitor | |||
| 0.029 | 0.028 | 0.029 | Calcitonin receptor agonist | |||
| 0.022 | 0.027 | 0.029 | Thyroid hormone agonist | 0.029 0.014 DBMET00975 | DBMET00975 | |
| 0.042 | 0.048 | 0.062 | Aldose reductase inhibitor | 0.062 0.031 DBMET00975 | DBMET00975 | |
| 0.071 | 0.079 | 0.074 | Inducible nitric-oxide synthase inhibitor | 0.074 0.073 DBMET00975 | DBMET00975 | |
| 0.049 | 0.061 | 0.214 | Selectin antagonist | 0.214 0.01 DBMET00975 | DBMET00975 | |
| 0.017 | 0.031 | 0.118 | Estrogen receptor beta agonist | 0.118 0.009 DBMET00975 | DBMET00975 | |
| 0.02 | 0.035 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 DBMET00975 | DBMET00975 | |
| 0.032 | 0.053 | 0.19 | Estrogen agonist | 0.19 0.009 DBMET00975 | DBMET00975 | |
| 0.03 | 0.069 | 0.094 | Carbonic anhydrase VB inhibitor | 0.094 0.017 DBMET00975 | DBMET00975 | |
| 0.012 | 0.052 | 0.02 | Glutamate (mGluR1a) agonist | 0.02 0.019 DBMET00975 | DBMET00975 | |
| 0.022 | 0.067 | 0.081 | Dopamine D2 agonist | 0.081 0.014 DBMET00975 | DBMET00975 | |
| 0.023 | 0.074 | 0.683 | Cholecystokinin B agonist | 0.683 0.001 DBMET00975 | DBMET00975 | |
| 0.096 | 0.147 | 0.382 | Diuretic | 0.382 0.014 DBMET00975 | DBMET00975 | |
| 0.04 | 0.093 | 0.197 | HIV-1 integrase (3'-Processing) inhibitor | 0.197 0.01 DBMET00975 | DBMET00975 | |
| 0.043 | 0.096 | 0.078 | Adenine nucleotide translocase inhibitor | 0.078 0.01 DBMET00975 | DBMET00975 | |
| 0.039 | 0.094 | 0.187 | Carbonic anhydrase V inhibitor | 0.187 0.008 DBMET00975 | DBMET00975 | |
| 0.042 | 0.1 | 0.132 | Carbonic anhydrase VA inhibitor | 0.132 0.015 DBMET00975 | DBMET00975 | |
| 0.035 | 0.101 | 0.09 | NMDA 2 receptor antagonist | 0.09 0.037 DBMET00975 | DBMET00975 | |
| 0.048 | 0.116 | 0.096 | HIV-1 integrase inhibitor | 0.096 0.027 DBMET00975 | DBMET00975 | |
| 0.024 | 0.092 | 0.116 | Leukocyte elastase inhibitor | 0.116 0.008 DBMET00975 | DBMET00975 | |
| 0.047 | 0.125 | 0.14 | CDC25A inhibitor | 0.14 0.014 DBMET00975 | DBMET00975 | |
| 0.025 | 0.127 | 0.148 | HIV-1 integrase (Strand Transfer) inhibitor | 0.148 0.013 DBMET00975 | DBMET00975 | |
| 0.06 | 0.164 | 0.085 | Protein kinase C zeta inhibitor | 0.085 0.076 DBMET00975 | DBMET00975 | |
| 0.047 | 0.16 | 0.165 | Protein-tyrosine phosphatase 1B inhibitor | 0.165 0.04 DBMET00975 | DBMET00975 | |
| 0.043 | 0.16 | 0.075 | Glycine receptor antagonist | 0.075 0.065 DBMET00975 | DBMET00975 | |
| 0.026 | 0.146 | 0.247 | NMDA 2B receptor antagonist | 0.247 0.005 DBMET00975 | DBMET00975 | |
| 0.087 | 0.208 | 0.327 | Platelet adhesion inhibitor | 0.327 0.026 DBMET00975 | DBMET00975 | |
| 0.076 | 0.197 | 0.469 | Anticoagulant | 0.469 0.012 DBMET00975 | DBMET00975 | |
| 0.005 | 0.134 | 0.717 | Cholecystokinin agonist | 0.717 0.002 DBMET00975 | DBMET00975 | |
| 0.035 | 0.163 | 0.103 | Thrombin inhibitor | 0.103 0.024 DBMET00975 | DBMET00975 | |
| 0.005 | 0.158 | 0.661 | Cholecystokinin A agonist | 0.661 0.002 DBMET00975 | DBMET00975 | |
| 0.042 | 0.198 | 0.071 | Chymotrypsin inhibitor | 0.071 0.068 DBMET00975 | DBMET00975 | |
| 0.063 | 0.228 | 0.277 | Protein-tyrosine phosphatase inhibitor | 0.277 0.024 DBMET00975 | DBMET00975 | |
| 0.004 | 0.178 | 0.115 | Estrone sulfatase inhibitor | 0.115 0.004 DBMET00975 | DBMET00975 | |
| 0.017 | 0.21 | 0.091 | Elastase inhibitor | 0.091 0.012 DBMET00975 | DBMET00975 | |
| 0.009 | 0.229 | 0.06 | NMDA 2D receptor antagonist | 0.06 0.005 DBMET00975 | DBMET00975 | |
| 0.004 | 0.226 | 0.343 | Cholecystokinin A antagonist | 0.343 0.004 DBMET00975 | DBMET00975 | |
| 0.014 | 0.251 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.014 DBMET00975 | DBMET00975 | |
| 0.005 | 0.265 | 0.288 | Cholecystokinin antagonist | 0.288 0.004 DBMET00975 | DBMET00975 | |
| 0.004 | 0.277 | 0.252 | Cholecystokinin B antagonist | 0.252 0.004 DBMET00975 | DBMET00975 | |
| 0.039 | 0.376 | 0.266 | Dual specificity phosphatase inhibitor | 0.266 0.035 DBMET00975 | DBMET00975 | |
| 0.037 | 0.569 | 0.227 | Angiogenesis inhibitor | 0.227 0.141 DBMET00975 | DBMET00975 | |
| 0.016 | 0.582 | 0.192 | Multidrug resistance-associated protein 1 inhibitor | 0.192 0.012 DBMET00975 | DBMET00975 | |
| 0.016 | 0.59 | 0.219 | Dual specificity phosphatase 3 inhibitor | 0.219 0.052 DBMET00975 | DBMET00975 | |
| 0.009 | 0.593 | 0.037 | Purinergic P2Y2 antagonist | 0.037 0.019 DBMET00975 | DBMET00975 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |